The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Stock and Other Ownership Interests - Blueprint Medicines; Caris Life Sciences; G1 Therapeutics; Merrimack
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Caris Life Sciences; Daiichi Sankyo; Eisai; EMD Serono; Janssen; Kolltan Pharmaceuticals; Merrimack; Novartis; PharmaMar
Research Funding - Bayer; Janssen; Novartis; Pfizer

Exploration of tumor genetic alterations and associations with clinical outcomes: Retrospective genomic analysis of archived liposarcoma (LPS) and leiomyosarcoma (LMS) samples from phase III trial of trabectedin (T) versus dacarbazine (D).
 
Shibu Thomas
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Shilpy Joshi
Employment - Janssen Research & Development
 
Dong Shen
No Relationships to Disclose
 
Roland Elmar Knoblauch
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson; Johnson & Johnson (I)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Michael Gormley
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
George C. Wang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Deborah S. Ricci
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
 
Clifford Motley
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Robert G. Maki
Honoraria - Lilly; Springer; Wiley
Consulting or Advisory Role - AADi; American Board of Internal Medicine (ABIM); Arcus Ventures; Bayer; Deciphera; Foundation Medicine; Janssen Scientific Affairs; Karyopharm Therapeutics; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); FORMA Therapeutics (Inst); Immunocore (Inst); Lilly (Inst); Pfizer (Inst); Presage Biosciences (Inst); Regeneron (Inst); TRACON Pharma (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Springer and Wiley: Books for contributions I have made to the published texts; Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer; TRACON Pharma
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; deciphera; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - Arog
Other Relationship - NCCN
 
Shreyaskumar Patel
Consulting or Advisory Role - Bayer; Bayer; CytRx Corporation; CytRx Corporation; Eisai; EMD Serono; Epizyme; Epizyme; Janssen; Lilly; Lilly; Morphotek; Novartis; Novartis
Research Funding - Eisai (Inst); Janssen (Inst); Morphotek (Inst)
 
George D. Demetri
No Relationships to Disclose